Drug Profile
MSI 469
Latest Information Update: 08 Aug 2007
Price :
$50
*
At a glance
- Originator Genaera Corporation
- Developer Colgate-Palmolive; Genaera Corporation
- Class Antibacterials; Antineoplastics; Peptide antibiotics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Periodontal disorders
Most Recent Events
- 20 Jul 1998 No-Development-Reported for Periodontal disorders in USA (Unknown route)
- 21 Nov 1995 New profile
- 21 Nov 1995 Preclinical development for Periodontal disorders in USA (Unknown route)